Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-03-01 @ 12:16 AM
Study NCT ID:
NCT02977312
Status:
COMPLETED
Last Update Posted:
2016-11-30
First Post:
2016-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
Sponsor:
Hikma Pharmaceuticals LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Cemivil-2011-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None